Navigation Links
AMRI’s John Iannone Named US Expert to ISO Technical Committee
Date:9/13/2017

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced that John Iannone, director of extractables/leachables & impurities, has been named a US expert to the International Standards Organization/Technical Committee 194: Biological and Clinical Evaluation of Medical Devices.

Through this appointment, Mr. Iannone will have the opportunity to participate in global ISO committee meetings and specifically discussions surrounding the changing regulatory landscape of ISO 10993, a set of international standards for evaluating the biocompatibility of medical devices. In addition, as a nominated subject matter expert, Mr. Iannone will further influence product safety guidelines and regulations. Only persons nominated as subject matter experts and accepted by the chairs of the respective working groups are allowed to attend in the international annual meeting.

"More than ever before, it is critical to understand the complex science of extractable and leachable assessments, as the chemistry involved has significant effect on the safety of medicines and medical devices," said Mr. Iannone. "With that knowledge, we can develop and implement expert solutions which adequately demonstrate safety and suitability of the many innovative products currently being introduced in the market. Through leveraging the multidisciplinary expertise of AMRI's technical team, I will continue to propose solutions to the guidelines in development and to our customers, current and future. This is an exciting time and am thrilled to be a contributor to the industry overall."

John Iannone serves as director of extractables/leachables (E&L) and impurities at AMRI. As a current candidate for board certification by the American Board of Toxicology (DABT), he ensures a strong tie to safety considerations in the AMRI E&L team. His areas of expertise include material qualification and biocompatibility, extractables and leachables, chemical characterization, and attainment of biological and/or toxicological risk assessments for medical devices, pharmaceutical container systems, bioprocessing systems, and combination products. John has given numerous technical presentations and has led several workshops on extractable and leachable considerations, biocompatibility, microbiology, toxicology, and regulatory testing requirements. He also participates in the development of both industry groups’ recommendations and regulatory guidelines through expert panel (USP) membership, global technical committees, and both industry and regulatory agency collaborations. In addition to leading the AMRI E&L lab operations, his responsibilities also include providing technical consultation to clients regarding unique testing strategies in an effort for them to meet global regulatory expectations. Prior to joining AMRI, Mr. Iannone served as a technical specialist at Toxikon. He has bachelor’s of bioengineering and biomedical engineering from Boston University.

Mr. Iannone will be speaking this evening on ISO 10993 standards as well as other topics relevant to extractables & leachables at Pharma Talk 2017 Dinner & Learn Series, occurring from 5:00 PM to 8:00 PM at the Heldrich Hotel in New Brunswick, New Jersey. In addition, AMRI will be available at tabletop 133 during Contract Pharma 2017, which occurs September 14-15 in New Brunswick.

AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical and Solid State Services, API Manufacturing and Drug Product. For more information about AMRI, visit http://www.amriglobal.com.

Contacts
Gina Rothe
gina.rothe(at)amriglobal.com
518-512-2512

Carolyn Hawley
carolyn(at)canalecomm.com
(619) 849-5382

Read the full story at http://www.prweb.com/releases/2017/09/prweb14682217.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. AMRI’s Global Analytical Services Introduces Comprehensive Forced Degradation Services To Meet Pharmaceutical Industry Demand
2. Benchworks Named to Inc. Magazine’s 36th Annual List of America’s Fastest-Growing Private Companies
3. DuPont and ADM Named Winners of 2017 Innovation in Bioplastics Award for Bio-Based Molecule Technology
4. Brian Pogue Named Editor of Journal of Biomedical Optics
5. Kinokuniya Company Ltd. named exclusive sales representative of SPIE Journals in Japan
6. Dr. Vincent Burton Named President of Okyanos Center for Regenerative Medicine
7. Cambridge Semantics Named SIIA Business Technology CODiE Award Winner for ‘Best Text Analytics and Semantic Technology Solution’
8. Cambridge Semantics Named SIIA Business Technology CODiE Award Finalist for ‘Best Text Analytics and Semantic Technology Solution’
9. Emil Andrusko of Benchworks Named One of the 2017 PM360 ELITE 100
10. Benchworks President Melissa Johnston Named Treasurer for Healthcare Businesswomen’s Association (HBA) Mid-Atlantic Chapter
11. Asymmetrex Named One of the "50 Most Valuable Brands of the Year 2017" by The Silicon Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):